Rezultati - Dingemans, Anne-Marie
- Showing 1 - 20 results of 70
- Go to Next Page
-
1
-
2
-
3
-
4
Reporting of Incidence and Outcome of Bone Metastases in Clinical Trials Enrolling Patients with Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma—A Systematic Review od Brouns, Anita, Dursun, Safiye, Bootsma, Gerben, Dingemans, Anne-Marie C., Hendriks, Lizza
Izdano 2021Text -
5
-
6
Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when? od Schoenmaekers, Janna Josephus Anna Oda, Paats, Marthe Sentijna, Dingemans, Anne-Marie Clasina, Hendriks, Lizza Elisabeth Lucia
Izdano 2020Text -
7
-
8
-
9
Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung canc... od Sanders, Karin J C, Degens, Juliette H R J, Dingemans, Anne-Marie C, Schols, Annemie M W J
Izdano 2019Text -
10
-
11
Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer od Dingemans, Anne-Marie C, van den Boogaart, Vivian, Vosse, Bettine A, van Suylen, Robert-Jan, Griffioen, Arjan W, Thijssen, Victor L
Izdano 2010Text -
12
Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study od Degens, Juliette, De Ruysscher, D, Houben, Ruud, Kietselaer, Bastiaan, Bootsma, Gerben, Hendriks, Lizza, Huijbers, Ellen, Schols, Annemie, Dingemans, Anne-Marie C
Izdano 2020Text -
13
Estimating quality adjusted progression free survival of first-line treatments for EGFR mutation positive non small cell lung cancer patients in The Netherlands od Verduyn, S Cora, Biesma, Bonne, Schramel, Franz MNH, van der Scheer, Feike W, Langenfeld, Merel K, de Peuter, Maria A, Dingemans, Anne-Marie C
Izdano 2012Text -
14
Galectin Expression Profiling Identifies Galectin-1 and Galectin-9Δ5 as Prognostic Factors in Stage I/II Non-Small Cell Lung Cancer od Schulkens, Iris A., Heusschen, Roy, van den Boogaart, Vivian, van Suylen, Robert-Jan, Dingemans, Anne-Marie C., Griffioen, Arjan W., Thijssen, Victor L.
Izdano 2014Text -
15
-
16
Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I–III small cell lung cancer: A hypothesis generating study od van Loon, Judith, Offermann, Claudia, Öllers, Michel, van Elmpt, Wouter, Vegt, Erik, Rahmy, Ali, Dingemans, Anne-Marie C., Lambin, Philippe, De Ruysscher, Dirk
Izdano 2011Text -
17
-
18
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? od Lind, Joline S. W., Meijerink, Martijn R., Dingemans, Anne-Marie C., van Kuijk, Cornelis, Öllers, Michel C., de Ruysscher, Dirk, Postmus, Pieter E., Smit, Egbert F.
Izdano 2010Text -
19
Non-Radiation Based Early Pain Relief Treatment Options for Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: A Systematic Review od Brouns, Anita J. W. M., De Bie, Ben H., van den Beuken-van Everdingen, Marieke H. J., Dingemans, Anne-Marie C., Hendriks, Lizza E. L.
Izdano 2020Text -
20
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy od van den Heuvel, Michel M, Verheij, Marcel, Boshuizen, Rogier, Belderbos, José, Dingemans, Anne-Marie C, De Ruysscher, Dirk, Laurent, Julien, Tighe, Robert, Haanen, John, Quaratino, Sonia
Izdano 2015Text